For women with low sex drive, the Food and Drug Administration has approved a new EpiPen-like drug that promises to boost libido. The FDA made the decision on Friday. The drug is somewhat similar to medications used to treat erectile dysfunction in men, in that they are meant to be used "on demand" — when a person wants to be sexually intimate. But that's where the similarity stops. Erectile dysfunction drugs work by increasing blood flow to a man's genitals. Bremelanotide, on the other hand, works by targeting a woman's brain chemistry.
A new drug for low sexual desire in women: Bremelanotide
Sex and Gender Differences in Substance Use | National Institute on Drug Abuse (NIDA)
Get the latest information from CDC coronavirus. Men are more likely than women to use almost all types of illicit drugs, 13 and illicit drug use is more likely to result in emergency department visits or overdose deaths for men than for women. For most age groups, men have higher rates of use or dependence on illicit drugs and alcohol than do women. Similar to other addictive drugs, fewer females than males use marijuana. Research indicates that marijuana impairs spatial memory in women more than it does in men, 22,23 while males show a greater marijuana-induced high. In one study specific to teenagers, male high school students who smoke marijuana reported poor family relationships and problems at school more often than female students who smoke marijuana. Animal studies show that female rats are more sensitive to the rewarding, 29,30 pain-relieving, 31—33 and activity-altering 31,33,34 effects of marijuana's main active ingredient, deltatetrahydrocannabinol THC.
A Pill That Boosts a Woman's Sex Drive Is Almost Here. But Do We Need It?
In its latest attempt to kick-start lady libidos with a pill, Sprout Pharmaceuticals announced this week that it will resubmit its female sex drug, flibanserin, for FDA approval. If it gets the okay, the drug would be the first prescription of its kind for women in the United States: a treatment for female hypoactive sexual disorder, or a low sex drive. More than a dozen drugs that address some kind of sexual dysfunction already are available in the US. But since Viagra's little blue pill hit the market, nearly all of the approved sex drugs have targeted men, despite the oft-cited statistic that nearly half of American women report some sexual dissatisfaction —notably more than their counterparts.
The intersection of drug use, sexual pleasure and sexual risk behavior is rarely explored when it comes to poor women who use drugs. This paper explores the relationship between sexual behavior and methamphetamine use in a community-based sample of women, exploring not only risk, but also desire, pleasure and the challenges of overcoming trauma. Data were integrated for mixed methods analysis. While many participants reported sexual risk behavior unprotected vaginal or anal intercourse in the quantitative survey, sexual risk was not the central narrative pertaining to sexual behavior and methamphetamine use in qualitative findings. Rather, desire, pleasure and disinhibition arose as central themes.